BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31494144)

  • 1. Breast cancer chemoprevention: An update on current practice and opportunities for primary care physicians.
    Ball S; Arevalo M; Juarez E; Payne JD; Jones C
    Prev Med; 2019 Dec; 129():105834. PubMed ID: 31494144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    Levine M; Moutquin JM; Walton R; Feightner J;
    CMAJ; 2001 Jun; 164(12):1681-90. PubMed ID: 11450210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.
    Kinsinger LS; Harris R; Woolf SH; Sox HC; Lohr KN
    Ann Intern Med; 2002 Jul; 137(1):59-69. PubMed ID: 12093250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Nelson HD; Fu R; Zakher B; Pappas M; McDonagh M
    JAMA; 2019 Sep; 322(9):868-886. PubMed ID: 31479143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.
    Reimers LL; Sivasubramanian PS; Hershman D; Terry MB; Greenlee H; Campbell J; Kalinsky K; Maurer M; Jayasena R; Sandoval R; Alvarez M; Crew KD
    Breast J; 2015; 21(4):377-86. PubMed ID: 25879521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of breast cancer.
    Thomsen A; Kolesar JM
    Am J Health Syst Pharm; 2008 Dec; 65(23):2221-8. PubMed ID: 19020189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of breast cancer: recommendations and rationale.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Jul; 137(1):56-8. PubMed ID: 12093249
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast cancer chemoprevention: A service in need of menopause specialist support.
    Marsden J
    Post Reprod Health; 2017 Mar; 23(1):15-21. PubMed ID: 28081658
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemoprevention.
    Vogel VG
    Curr Drug Targets; 2011 Dec; 12(13):1874-87. PubMed ID: 21158712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective estrogen receptor modulators in breast cancer prevention.
    Li F; Dou J; Wei L; Li S; Liu J
    Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summaries for patients. Using medication to prevent breast cancer: recommendations from the United States Preventive Services Task Force.
    Ann Intern Med; 2002 Jul; 137(1):I62. PubMed ID: 12093267
    [No Abstract]   [Full Text] [Related]  

  • 12. Exemestane for primary prevention of breast cancer in postmenopausal women.
    Zhang Y; Simondsen K; Kolesar JM
    Am J Health Syst Pharm; 2012 Aug; 69(16):1384-8. PubMed ID: 22855103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention or mastectomy for women at high risk of developing breast cancer.
    Sismondi P; D'Alonzo M; Pecchio S; Bounous VE; Robba E; Biglia N
    Maturitas; 2015 Nov; 82(3):271-3. PubMed ID: 26276104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From adjuvant therapy to breast cancer prevention: BCPT and STAR.
    Dunn BK; Ford LG
    Breast J; 2001; 7(3):144-57. PubMed ID: 11469927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of breast cancer: implications for postmenopausal women.
    Fabian CJ; Kimler BF
    Drugs Aging; 2002; 19(1):43-78. PubMed ID: 11929326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer Chemoprevention: A Practical Guide for the Primary Care Provider.
    Farkas A; Vanderberg R; Merriam S; DiNardo D
    J Womens Health (Larchmt); 2020 Jan; 29(1):46-56. PubMed ID: 31560601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.
    Crew KD
    Am Soc Clin Oncol Educ Book; 2015; ():e50-8. PubMed ID: 25993215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in breast cancer chemoprevention.
    Chlebowski RT
    Pol Arch Med Wewn; 2014; 124(4):191-9. PubMed ID: 24618912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of breast cancer.
    Dalton RR; Kallab AM
    South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010.
    Waters EA; McNeel TS; Stevens WM; Freedman AN
    Breast Cancer Res Treat; 2012 Jul; 134(2):875-80. PubMed ID: 22622807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.